Patents by Inventor Lea Anne Harrington

Lea Anne Harrington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polynucleotides encoding a telomerase component TP2
    Patent number: 7390891
    Abstract: Disclosed are nucleic acid molecules encoding polypeptides of the telomerase complex. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: October 16, 1997
    Date of Patent: June 24, 2008
    Assignee: Amgen Inc.
    Inventors: Lea Anne Harrington, Murray O. Robinson
  • Genes encoding telomerase protein 1
    Patent number: 6174703
    Abstract: Disclosed are nucleic acid molecules encoding polypeptides that specifically bind telomerase RNA. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: November 2, 1998
    Date of Patent: January 16, 2001
    Assignees: Amgen Inc., Amgen Canada Inc.
    Inventors: Lea Anne Harrington, Murray O. Robinson
  • Genes encoding telomerase protein 1
    Patent number: 5981707
    Abstract: Disclosed are nucleic acid molecules encoding polypeptides that specifically bind telomerase RNA. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: April 15, 1998
    Date of Patent: November 9, 1999
    Assignees: Amgen Inc., Amgen Canada Inc.
    Inventors: Lea Anne Harrington, Murray O. Robinson
  • Genes encoding telomerase protein 1
    Patent number: 5919656
    Abstract: Disclosed are nucleic acid molecules encoding polypeptides that specifically bind telomerase RNA. Also disclosed are methods of preparing the nucleic acid molecules and polypeptides, and methods of using these molecules.
    Type: Grant
    Filed: November 15, 1996
    Date of Patent: July 6, 1999
    Assignees: Amgen Canada Inc., Amgen Inc.
    Inventors: Lea Anne Harrington, Murray O. Robinson